DDInter 2.0: Drug-Drug Interactions — ATC L (Antineoplastic and immunomodulating agents)

Zusammenfassung

Drug-Drug Interactions for asparaginase escherichia coli Source: DDInter 2.0 (ddinter2.scbdd.com) Total interactions: 392 (29 Major, 363 Moderate, 0 Minor) - Adalimumab: Major interaction - Baricitinib: Major interaction - Bacillus calmette-guerin substrain tice live antigen: Major interaction - Bexarotene: Major interaction - Certolizumab pegol: Major interaction - Cladribine: Major interaction - Clozapine: Major interaction - Etanercept: Major interaction - Fingolimod: Major interaction - Gol

Kerninformationen

Major interaction - Pexidartinib: Major interaction - Rotavirus vaccine: Major interaction - Rubella virus vaccine: Major interaction - Siponimod: Major interaction - Talimogene laherparepvec: Major interaction - Teriflunomide: Major interaction - Thalidomide: Major interaction - Tofacitinib: Major...

teraction - Ketorolac: Moderate interaction - Clostridium tetani toxoid antigen (formaldehyde inactivated): Moderate interaction - Trastuzumab emtansine: Moderate interaction - Ibuprofen: Moderate interaction - Afatinib: Moderate interaction - Levonorgestrel: Moderate interaction - Hydrocortisone: M...

n: Moderate interaction - Pioglitazone: Moderate interaction - Ethinylestradiol: Moderate interaction - Diclofenac (topical): Moderate interaction - Ambrisentan: Moderate interaction - Amiodarone: Moderate interaction - Benazepril: Moderate interaction - Celecoxib: Moderate interaction - Clavulanic ...

Fragen zu diesem Thema?

ClariMed durchsucht alle Leitlinien mit KI und liefert quellenbasierte Antworten in Sekunden.

Jetzt auf ClariMed suchen